Cathie Wood’s ARK Invest Shifts Portfolio Toward Biotech and Fintech, Boosts Intellia and Block
Cathie Wood's ARK Invest made significant portfolio adjustments on October 27, 2025, doubling down on biotech and fintech plays. The firm acquired 750,115 shares of gene-editing specialist Intellia Therapeutics (NTLA) worth $19.2 million across its ARK Innovation and ARK Genomic Revolution ETFs. This marks a continued bullish stance on CRISPR-based therapeutics.
ARK also deployed $30.7 million into Block (XYZ), the digital payments firm formerly known as Square. The purchase spanned three ETFs—ARK Innovation, ARK Next Generation Internet, and ARK Fintech Innovation—signaling conviction in the company's role in financial infrastructure.
Smaller positions were added in e-commerce giants Amazon (AMZN) and Alibaba (BABA), while reducing exposure to Shopify and other growth names. The moves reflect Wood's signature strategy of betting on disruptive innovation, particularly in genomic revolution and decentralized finance sectors.
